3/21/2023  3:32:47 PM Chg. -4.88 Volume Bid3/21/2023 Ask3:32:53 PM Market Capitalization Dividend Y. P/E Ratio
129.88EUR -3.62% 123,777
Turnover: 7.26 mill.
129.80Bid Size: 56 129.90Ask Size: 65 11.56 bill.EUR 0.70% 48.96

Business description

Carl Zeiss Meditec AG, which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The Company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of ZEISS is rounded off by promising future technologies such as intraoperative radiation therapy.

Management board & Supervisory board

Dr. Markus Weber
Management board
Justus Felix Wehmer, Jan Willem de Cler
Supervisory board
Dr. Karl Lamprecht, Cornelia Grandy, Dr. Christian Müller, Dr. Markus Guthoff, Isabel De Paoli, Jeffrey Marx, Peter Kameritsch, Prof. Dr. Michael Kaschke, René Denner, Tania von der Goltz, Torsten Reitze

Company data

Name: Carl Zeiss Meditec AG
Address: Göschwitzer Straße 51-52,D-07745 Jena
Phone: +49-3641-220-0
Fax: +49-3641-220-117
E-mail: info@meditec.zeiss.com
Internet: zeiss.de/corporate/home.html
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 9/30
Free Float: 21.19%
IPO date: 3/22/2000

Investor relations

Name: Sebastian Frericks
IR phone: +49-3641-220-116
IR Fax: -
IR e-mail: investors.meditec@zeiss.com

Company calendar

CW 12 | 3/22/2023 General Shareholder Meeting
CW 19 | 5/9/2023 Interim Report 2nd Quarter/6 Months
CW 31 | 8/4/2023 Interim Report 3rd Quarter/9 Months
CW 50 | 12/12/2023 4th Quarter/Annual Report

Main Shareholders

Carl Zeiss Gruppe
The Capital Group Companies, Inc.
ODDO et Cie.
Baillie Gifford & Co
BlackRock, Inc.
Invesco Ltd.
Oppenheimer International Small-Mid Company Fund